| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $16.21B | -12.3% |
| R&D Expense | $98.0M | +3.2% |
| SG&A Expense | $717.0M | +5.6% |
| Interest Expense | $298.0M | +8.8% |
| Pre-tax Income | $818.0M | +1.5% |
| Income Tax | $218.0M | +48.3% |
| Net Income | $600.0M | -8.8% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.31B | -12.6% |
| Inventory | $2.52B | -7.8% |
| Current Assets | $5.94B | -8.0% |
| Total Assets | $14.63B | +1.8% |
| Current Liabilities | $4.83B | -1.3% |
| Long-term Debt | $4.88B | -1.3% |
| Total Liabilities | $10.82B | -0.8% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.31B | +8.9% |
| Investing Cash Flow | -$1.39B | -79.1% |
| Financing Cash Flow | -$98.0M | -508.3% |
| Stockholders' Equity |
| $3.80B |
| +10.4% |